Search Results
10
Everything
Search Filters
Tag
Als
Tiziana Life Sciences Files Investigational New Drug Application with FDA for ALS Phase 2 Clinical Trial
March 04, 2025 08:00 ET
|
Tiziana Life Sciences Ltd.
NEW YORK, March 04, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with...
Athira Pharma Reports Full Year 2024 Financial Results and Pipeline and Business Updates
February 27, 2025 16:05 ET
|
Athira Pharma, Inc.
Completed healthy volunteer Phase 1 clinical study of ATH-1105 as a potential treatment for amyotrophic lateral sclerosis (ALS) On-track to enable dosing ALS patients in 2025 BOTHELL, Wash., Feb. ...
Robert Califf, MD, MAAC, to Deliver Keynote Address at 2025 MDA Clinical & Scientific Conference
February 27, 2025 09:00 ET
|
Muscular Dystrophy Association
New York, Feb. 27, 2025 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) announced today that Robert Califf, MD, MAAC, former Commissioner of the U.S. Food and Drug Administration and...
Muscular Dystrophy Association Launches Nation's Largest St. Patrick’s Day Fundraising Campaign Celebrating 75 Years of Progress
February 18, 2025 15:27 ET
|
Muscular Dystrophy Association
New York, Feb. 18, 2025 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) today launched the nation’s largest St. Patrick’s Day fundraising campaign, MDA Shamrocks, as part of its...
uniQure Announces Favorable Recommendation from Independent Data Monitoring Committee for its Phase I/II EPISOD1 Clinical Trial of AMT-162 for the Treatment of SOD1-ALS
January 30, 2025 07:37 ET
|
uniQure Inc.
~ Independent Data Monitoring Committee Recommends Proceeding with Dose Escalation After Planned Safety Assessment of First Dose Cohort ~ ~ Company Expects to Initiate Enrollment of Second Dose...
MDA Launches 75th Anniversary Campaign and Premieres New PSA to Shine a Light on Rare Diseases
January 28, 2025 09:00 ET
|
Muscular Dystrophy Association
New York, Jan. 28, 2025 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) proudly announces the launch of its 75th anniversary campaign, marking a legacy of progress in research, care,...
The Sundogs to Host The Tom Petty Show at Variety Playhouse on 2/1, Supporting ALS Research
January 15, 2025 11:20 ET
|
The Sundogs
ATLANTA, Jan. 15, 2025 (GLOBE NEWSWIRE) -- Beloved local rock n’ roll band The Sundogs have announced their 12th annual Tom Petty Show, will be held Saturday, Feb. 1 at Variety Playhouse in the...
Tiziana Life Sciences Announces Review Article Published in Nature Highlighting Foralumab's Potential in the Treatment of Neurological Disease
January 08, 2025 07:00 ET
|
Tiziana Life Sciences Ltd.
NEW YORK, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with...
Muscular Dystrophy Association and AFM-Téléthon Announce $510,000 Research Grant Awards Advancing Treatments for Mitochondrial Myopathies and ALS
December 18, 2024 08:44 ET
|
Muscular Dystrophy Association
New York, Dec. 18, 2024 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) and AFM-Téléthon (the French muscular dystrophy association) are proud to announce the awarding of two...
Muscular Dystrophy Association Announces Over $5 Million in Research Grants to Advance Neuromuscular Disease Research
December 16, 2024 08:42 ET
|
Muscular Dystrophy Association
New York, Dec. 16, 2024 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) announced today the awarding of 21 new grants with a total funding commitment of over $5 million toward...